Theratechnologies Quote - THTX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.79

Bid

1.38

Ask

1.97

Volume

372,331

1.5302 Day's Range 1.80

1.08 52 Week Range 2.58

Market Cap

82.304M

Previous Close

1.66

Open

1.68

Last Trade

1.8

Last Trade Time

Financial Volume

US$ 637,266

VWAP

1.7116

Average Volume (3m)

62,535

Shares Outstanding

45,980,019

Dividend Yield

PE Ratio

-3.40

Earnings Per Share (EPS)

-0.52

Revenue

81.76M

Net Profit

-23.96M

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.theratech.com

Headquarters

Quebec City, Quebec, Can

Founded

Theratechnologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker THTX. The last closing price for Theratechnologies was US$1.66. Over the last year, Theratechnologies shares have traded in a share price range of US$ 1.08 to US$ 2.58.

Theratechnologies currently has 45,980,019 shares outstanding. The market capitalization of Theratechnologies is US$76.33 million. Theratechnologies has a price to earnings ratio (PE ratio) of -3.40.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment

MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA

MONTREAL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer

No dose-limiting toxicities reported in two different weekly doses in heavily pre-treated patients Preliminary evidence of dose response includes significant tumor shrinkage and one patient with...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada

Addition of investigational RNA-targeted medicines build upon Theratechnologies’ foundational HIV portfolio Submissions to Health Canada planned for 2025 MONTREAL, Dec. 04, 2024 (GLOBE...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.38	26.9503546099	1.41	1.8499	1.4	195051	1.67936167	CS
4	0.58	47.9338842975	1.21	1.8499	1.12	110988	1.51393374	CS
12	0.54	43.2	1.25	1.8499	1.12	62535	1.40900924	CS
26	0.44	32.5925925926	1.35	1.8499	1.12	50497	1.40557713	CS
52	0.18	11.1801242236	1.61	2.58	1.08	50013	1.52541525	CS
156	-10.73	-85.7028753994	12.52	13.04	0.88	114234	4.45107804	CS
260	-9.33	-83.9028776978	11.12	17.8396	0.88	152066	8.25108801	CS

THTX - Frequently Asked Questions (FAQ)

What is the current Theratechnologies share price?

The current share price of Theratechnologies is US$ 1.79

How many Theratechnologies shares are in issue?

Theratechnologies has 45,980,019 shares in issue

What is the market cap of Theratechnologies?

The market capitalisation of Theratechnologies is USD 76.33M

What is the 1 year trading range for Theratechnologies share price?

Theratechnologies has traded in the range of US$ 1.08 to US$ 2.58 during the past year

What is the PE ratio of Theratechnologies?

The price to earnings ratio of Theratechnologies is -3.4

What is the cash to sales ratio of Theratechnologies?

The cash to sales ratio of Theratechnologies is 1

What is the reporting currency for Theratechnologies?

Theratechnologies reports financial results in USD

What is the latest annual turnover for Theratechnologies?

The latest annual turnover of Theratechnologies is USD 81.76M

What is the latest annual profit for Theratechnologies?

The latest annual profit of Theratechnologies is USD -23.96M

What is the registered address of Theratechnologies?

The registered address for Theratechnologies is 2015 PEEL STREET, 5TH FLOOR, QUEBEC CITY, QUEBEC, H3A 1T8

What is the Theratechnologies website address?

The website address for Theratechnologies is www.theratech.com

Which industry sector does Theratechnologies operate in?

Theratechnologies operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M